Anavex Life Sciences Corp - Company & Market Research Reports

Anavex Life Sciences is a biopharmaceutical company that develops differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, including drug candidates to treat diseases of the central nervous system, pain and various types of cancer. The company's best known product is ANAVEXTM 2-73, a compound being developed to treat Alzheimer's disease, Parkinson's disease and related diseases. The company was founded in 2006 and is based in New York.

From
From
Neuropathic Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2017

  • Drug Pipelines
  • 488 Pages
From
Neuropathic Pain - Pipeline Review, H1 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H1 2017

  • Drug Pipelines
  • 485 Pages
From
From
Alzheimer's Disease - Pipeline Review, H2 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2018

  • Drug Pipelines
  • 1333 Pages
From
Alzheimer's Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1203 Pages
From
From
Prostate Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2069 Pages
From
Depression - Pipeline Review, H2 2018 - Product Thumbnail Image

Depression - Pipeline Review, H2 2018

  • Drug Pipelines
  • 504 Pages
From
Depression - Pipeline Review, H1 2018 - Product Thumbnail Image

Depression - Pipeline Review, H1 2018

  • Drug Pipelines
  • 490 Pages
From
From
From
Fragile X Syndrome - Pipeline Review, H2 2018 - Product Thumbnail Image

Fragile X Syndrome - Pipeline Review, H2 2018

  • Drug Pipelines
  • 135 Pages
From
Rett Syndrome - Pipeline Review, H2 2018 - Product Thumbnail Image

Rett Syndrome - Pipeline Review, H2 2018

  • Drug Pipelines
  • 122 Pages
From
Rett Syndrome - Pipeline Review, H1 2018 - Product Thumbnail Image

Rett Syndrome - Pipeline Review, H1 2018

  • Drug Pipelines
  • 114 Pages
From
Epilepsy - Pipeline Review, H2 2018 - Product Thumbnail Image

Epilepsy - Pipeline Review, H2 2018

  • Drug Pipelines
  • 410 Pages
From
Dementia - Pipeline Review, H2 2018 - Product Thumbnail Image

Dementia - Pipeline Review, H2 2018

  • Drug Pipelines
  • 302 Pages
From
From
Loading Indicator
adroll